Biologic

Biologic

Biologics are a category of medical products derived from living organisms. They include a wide range of products such as vaccines, blood components, gene therapies, tissues, and recombinant proteins. Biologics are used in the prevention, diagnosis, and treatment of various diseases and medical conditions.

History

The development of biologics dates back to the late 19th century with the advent of vaccination. The first biologic product was the smallpox vaccine, developed by Edward Jenner in 1796. Since then, the field has expanded significantly, especially with the advent of recombinant DNA technology in the 1970s, which allowed for the production of complex proteins and monoclonal antibodies.

Types of Biologics

Biologics can be classified into several categories based on their source and function:

Vaccines

Vaccines are biological preparations that provide immunity to a particular infectious disease. They contain agents that resemble a disease-causing microorganism and are often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

Blood and Blood Components

These include whole blood, red blood cells, platelets, and plasma. They are used in transfusions and to treat various blood disorders.

Gene Therapy

Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This innovative approach holds promise for treating genetic disorders, some types of cancer, and viral infections.

Recombinant Proteins

Recombinant proteins are proteins that are engineered in the laboratory through recombinant DNA technology. Examples include insulin, growth hormones, and monoclonal antibodies.

Tissues

Biologic tissues are used in transplantation and include skin, bone, and heart valves. These tissues are often used to repair or replace damaged tissues in patients.

Production

The production of biologics is complex and involves several steps:

1. Cell Line Development: The first step involves creating a cell line that can produce the desired biologic product. This often involves genetic engineering of cells to express the target protein.
2. Cultivation: The cells are then cultivated in bioreactors under controlled conditions to produce the biologic product.
3. Purification: The product is extracted and purified to remove any contaminants or impurities.
4. Formulation: The purified product is formulated into a final product that can be administered to patients.

Regulation

Biologics are regulated by health authorities such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe. These agencies ensure that biologics are safe, effective, and of high quality before they can be marketed.

Challenges

The development and production of biologics pose several challenges:

• Complexity: Biologics are more complex than small molecule drugs, making them more difficult to characterize and manufacture.
• Cost: The production of biologics is often more expensive due to the complexity of the processes involved.
• Stability: Biologics are often less stable than small molecule drugs and may require special storage conditions.

Future Directions

The field of biologics is rapidly evolving with advancements in biotechnology and genomics. New technologies such as CRISPR and synthetic biology are paving the way for the development of novel biologic therapies.

See Also

• Monoclonal antibody
• Biopharmaceutical
• Biosimilar

References

• Gary,

 Biopharmaceuticals: Biochemistry and Biotechnology, 
  
 John Wiley & Sons, 
 2013, 
  
  
 ISBN 978-1118687383,

• Rader, RA,

 Biopharmaceuticals in the U.S. and European Markets: 20 Years of Development, 
 Nature Biotechnology, 
 2008,
 Vol. 26(Issue: 8),
 pp. 855-860,
 DOI: 10.1038/nbt0808-855,